Brand Name | Status | Last Update |
---|---|---|
aminosyn ii | New Drug Application | 2022-05-04 |
aminosyn-pf | New Drug Application | 2022-07-21 |
clinimix | New Drug Application | 2021-04-13 |
clinimix e | New Drug Application | 2021-04-13 |
clinisol | ANDA | 2018-06-01 |
enbrace hr | unapproved drug other | 2025-01-02 |
enlyte | unapproved drug other | 2022-07-01 |
kabiven | New Drug Application | 2023-08-02 |
paxlyte | unapproved drug other | 2024-12-19 |
perikabiven | New Drug Application | 2023-08-07 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 6 | 8 | 3 | 45 | 63 |
Thromboembolism | D013923 | — | — | 3 | 8 | 15 | 1 | 19 | 45 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | 1 | 7 | 14 | 1 | 18 | 41 |
Thrombosis | D013927 | — | — | 7 | 6 | 10 | 1 | 14 | 37 |
Embolism | D004617 | — | — | 2 | — | 7 | 3 | 13 | 25 |
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 4 | 3 | 7 | 14 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 4 | 1 | 5 | 11 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 1 | 4 | 1 | 2 | 8 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | 2 | 2 | 2 | 6 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | 1 | 2 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Venous thrombosis | D020246 | — | I82.40 | 4 | 5 | 6 | — | 9 | 24 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | 2 | 1 | — | 4 | 7 |
Neoplasms | D009369 | — | C80 | 1 | — | 3 | — | 1 | 5 |
Surgical blood loss | D016063 | — | — | — | — | 4 | — | — | 4 |
Renal insufficiency | D051437 | — | N19 | 1 | — | 1 | — | 2 | 4 |
Postoperative hemorrhage | D019106 | — | — | — | — | 2 | — | 1 | 3 |
Infarction | D007238 | EFO_0009463 | — | — | — | 2 | — | 1 | 3 |
Heart failure | D006333 | EFO_0003144 | I50 | — | — | 2 | — | 1 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | 1 | 2 |
Rheumatic diseases | D012216 | — | M79.0 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ischemic stroke | D000083242 | — | — | — | 1 | — | — | 2 | 3 |
Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | 2 | 3 |
Ischemia | D007511 | EFO_0000556 | — | — | 1 | — | — | 1 | 2 |
Hemophilia a | D006467 | EFO_0007267 | D66 | 1 | 1 | — | — | — | 2 |
Bariatric surgery | D050110 | — | — | 1 | 1 | — | — | — | 2 |
Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | — | 1 | — | — | — | 1 |
Cerebral infarction | D002544 | — | I63 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 8 | — | — | — | — | 8 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Biological availability | D001682 | — | — | 2 | — | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Medical sociology | D012962 | — | — | 1 | — | — | — | — | 1 |
Morbid obesity | D009767 | EFO_0001074 | — | 1 | — | — | — | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
Disease | D004194 | EFO_0000408 | R69 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Replacement arthroplasty hip | D019644 | — | — | — | — | — | — | 2 | 2 |
Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | — | — | 1 | 1 |
Disease progression | D018450 | — | — | — | — | — | — | 1 | 1 |
Brain ischemia | D002545 | EFO_0003883 | I67.82 | — | — | — | — | 1 | 1 |
Bronchiectasis | D001987 | — | J47 | — | — | — | — | 1 | 1 |
Congenital heart defects | D006330 | — | Q24.9 | — | — | — | — | 1 | 1 |
Fontan procedure | D018729 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Serine |
INN | dexfosfoserine |
Description | L-serine is the L-enantiomer of serine. It has a role as a human metabolite, an algal metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a serine family amino acid, a proteinogenic amino acid, a L-alpha-amino acid and a serine. It is a conjugate base of a L-serinium. It is a conjugate acid of a L-serinate. It is an enantiomer of a D-serine. It is a tautomer of a L-serine zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](CO)C(=O)O |
PDB | — |
CAS-ID | 56-45-1 |
RxCUI | — |
ChEMBL ID | CHEMBL11298 |
ChEBI ID | 17115 |
PubChem CID | 5951 |
DrugBank | DB00133 |
UNII ID | VI4F0K069V (ChemIDplus, GSRS) |